AstraZeneca may buck a decade of pharma strategy to buy U.S. scale
Reports of preliminary talks between AstraZeneca and Bristol Myers Squibb moved shares and reignited debate over Big Pharma consolidation.
This is a summary aggregated from CNBC. Read the complete article on the original site:
Read full article at CNBC
